82_FR_28793 82 FR 28673 - National Institute on Drug Abuse; Notice of Closed Meetings

82 FR 28673 - National Institute on Drug Abuse; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 82, Issue 120 (June 23, 2017)

Page Range28673-28674
FR Document2017-13078

Federal Register, Volume 82 Issue 120 (Friday, June 23, 2017) 
[Federal Register Volume 82, Number 120 (Friday, June 23, 2017)]
[Notices]
[Pages 28673-28674]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-13078]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; Summer Research Education Experience Programs (R25).
    Date: June 30, 2017.
    Time: 11:00 a.m. to 1:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852 (Telephone Conference 
Call).
    Contact Person: Julia Berzhanskaya, Ph.D., Scientific Review 
Officer, Office of Extramural Policy and Review, Division of 
Extramural Research, National Institute on Drug Abuse, NIH, DHHS, 
6001 Executive Boulevard, Room 4234, MSC 9550, Bethesda, MD 20892, 
301-827-5840, [email protected].

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; Exploratory Studies of Smoking Cessation 
Interventions for People with Schizophrenia (R21/R33; R33).
    Date: July 12, 2017.
    Time: 2:30 p.m. to 5:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852 (Telephone Conference 
Call).
    Contact Person: Julia Berzhanskaya, Ph.D., Scientific Review 
Officer, Office of Extramural Policy and Review, Division of 
Extramural Research, National Institute on Drug Abuse, NIH, DHHS, 
6001 Executive Boulevard, Room 4234, MSC 9550, Bethesda, MD 20892, 
301-827-5840, [email protected].

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; Evaluating the NIDA Standardized Research E-
Cigarette in Risk Reduction and Related Studies (U01).
    Date: July 21, 2017.
    Time: 8:30 a.m. to 5:00 p.m.
    Agenda: To review and evaluate cooperative agreement 
applications.
    Place: Courtyard by Marriott Chevy Chase, 5520 Wisconsin Avenue, 
Chevy Chase, MD 20815.
    Contact Person: Julia Berzhanskaya, Ph.D., Scientific Review 
Officer, Office of Extramural Policy and Review, Division of 
Extramural Research, National Institute on Drug Abuse, NIH, DHHS, 
6001 Executive Boulevard, Room 4234, MSC 9550, Bethesda,

[[Page 28674]]

MD 20892, 301-827-5840, [email protected].

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; Expanding Medication Assisted Treatment for Opioid 
Use Disorders in the Context of the SAMHSA Opioid STR Grants (R21/
R33).
    Date: July 25, 2017.
    Time: 12:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852 (Telephone Conference 
Call).
    Contact Person: Hiromi Ono, Ph.D., Scientific Review Officer, 
Office of Extramural Policy and Review, National Institute on Drug 
Abuse, National Institutes of Health, DHHS, 6001 Executive 
Boulevard, Room 4238, MSC 9550, Bethesda, MD 20892, 301-827-5820, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug 
Abuse and Addiction Research Programs, National Institutes of 
Health, HHS)

    Dated: June 19, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-13078 Filed 6-22-17; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 82, No. 120 / Friday, June 23, 2017 / Notices 28673 encouraged to access the meeting Web Background Information on the RoC: provisions set forth in sections page to stay abreast of the most current Published biennially, each edition of the 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., information regarding the meeting. RoC is cumulative and consists of as amended. The grant applications and Request for Comments: NTP invites substances newly reviewed in addition the discussions could disclose written and oral public comments on to those listed in previous editions. For confidential trade secrets or commercial the draft monograph. The deadline for each listed substance, the RoC contains property such as patentable material, submission of written comments is July a substance profile, which provides and personal information concerning 14, 2017, to enable review by the peer information on cancer studies that individuals associated with the grant review panel and NTP staff prior to the support the listing—including those in applications, the disclosure of which meeting. Registration to provide oral humans, animals, and studies on would constitute a clearly unwarranted comments is by July 14, 2017, at https:// possible mechanisms of action— invasion of personal privacy. ntp.niehs.nih.gov/go/38853. Public information about potential sources of Name of Committee: National Institute on comments and any other exposure to humans, and current federal Drug Abuse Special Emphasis Panel; correspondence on the draft monograph regulations to limit exposures. The 14th Summer Research Education Experience should be sent to the FOR FURTHER RoC, the latest edition, was published Programs (R25). INFORMATION CONTACT. Persons on November 3, 2016 (available at Date: June 30, 2017. submitting written comments should https://ntp.niehs.nih.gov/go/roc14). Time: 11:00 a.m. to 1:00 p.m. include their name, affiliation, mailing Background Information on NTP Peer Agenda: To review and evaluate grant address, phone, email, and sponsoring Review Panels: NTP panels are applications. organization (if any). Written comments Place: National Institutes of Health, technical, scientific advisory bodies Neuroscience Center, 6001 Executive received in response to this notice will established on an ‘‘as needed’’ basis to Boulevard, Rockville, MD 20852 (Telephone be posted on the NTP Web site, and the provide independent scientific peer Conference Call). submitter will be identified by name, review and advise the NTP on agents of Contact Person: Julia Berzhanskaya, Ph.D., affiliation, and/or sponsoring public health concern, new/revised Scientific Review Officer, Office of organization (if any). Guidelines for toxicological test methods, or other Extramural Policy and Review, Division of public comments are at https:// issues. These panels help ensure Extramural Research, National Institute on ntp.niehs.nih.gov/ntp/about_ntp/ transparent, unbiased, and scientifically Drug Abuse, NIH, DHHS, 6001 Executive guidelines_public_comments_508.pdf. Boulevard, Room 4234, MSC 9550, Bethesda, rigorous input to the program for its use MD 20892, 301–827–5840, Public comment at this meeting is in making credible decisions about welcome, with time set aside for the julia.berzhanskaya@nih.gov. human hazard, setting research and This notice is being published less than 15 presentation of oral comments on the testing priorities, and providing draft monograph. In addition to in- days prior to the meeting due to the timing information to regulatory agencies about limitations imposed by the review and person oral comments at the NIEHS, alternative methods for toxicity funding cycle. public comments can be presented by screening. NTP welcomes nominations Name of Committee: National Institute on teleconference line. There will be 50 of scientific experts for upcoming Drug Abuse Special Emphasis Panel; lines for this call; availability is on a panels. Scientists interested in serving Exploratory Studies of Smoking Cessation first-come, first-served basis. The lines on an NTP panel should provide current Interventions for People with Schizophrenia will be open from 8:30 a.m. until curriculum vitae to the FOR FURTHER (R21/R33; R33). adjournment at approximately 4:00 p.m. INFORMATION CONTACT (see above). The Date: July 12, 2017. EDT on July 24, 2017, although oral Time: 2:30 p.m. to 5:30 p.m. authority for NTP panels is provided by Agenda: To review and evaluate grant comments will be received only during 42 U.S.C. 217a; section 222 of the Public the formal public comment periods applications. Health Service (PHS) Act, as amended. Place: National Institutes of Health, indicated on the preliminary agenda. The panel is governed by the Federal Neuroscience Center, 6001 Executive The access number for the Advisory Committee Act, as amended (5 Boulevard, Rockville, MD 20852 (Telephone teleconference line will be provided to U.S.C. Appendix 2), which sets forth Conference Call). registrants by email prior to the meeting. Contact Person: Julia Berzhanskaya, Ph.D., standards for the formation and use of Each organization is allowed one time Scientific Review Officer, Office of advisory committees. slot. At least 7 minutes will be allotted Extramural Policy and Review, Division of to each time slot, and if time permits, Dated: June 6, 2017. Extramural Research, National Institute on the allotment may be extended to 10 John R. Bucher, Drug Abuse, NIH, DHHS, 6001 Executive minutes at the discretion of the chair. Associate Director, National Toxicology Boulevard, Room 4234, MSC 9550, Bethesda, Persons wishing to make an oral Program. MD 20892, 301–827–5840, julia.berzhanskaya@nih.gov. presentation are asked to register online [FR Doc. 2017–13159 Filed 6–22–17; 8:45 am] at https://ntp.niehs.nih.gov/go/38853 by Name of Committee: National Institute on BILLING CODE 4140–01–P Drug Abuse Special Emphasis Panel; July 14, 2017, and indicate whether they Evaluating the NIDA Standardized Research will present comments in-person or via E-Cigarette in Risk Reduction and Related the teleconference line. If possible, oral DEPARTMENT OF HEALTH AND Studies (U01). public commenters should send a copy HUMAN SERVICES Date: July 21, 2017. of their slides and/or statement or Time: 8:30 a.m. to 5:00 p.m. talking points at that time. Written National Institutes of Health Agenda: To review and evaluate cooperative agreement applications. asabaliauskas on DSKBBXCHB2PROD with NOTICES statements can supplement and may expand the oral presentation. National Institute on Drug Abuse; Place: Courtyard by Marriott Chevy Chase, Registration for in-person oral Notice of Closed Meetings 5520 Wisconsin Avenue, Chevy Chase, MD 20815. comments will also be available at the Pursuant to section 10(d) of the Contact Person: Julia Berzhanskaya, Ph.D., meeting, although time allowed for Federal Advisory Committee Act, as Scientific Review Officer, Office of presentation by on-site registrants may amended (5 U.S.C. App), notice is Extramural Policy and Review, Division of be less than that for registered speakers hereby given of the following meetings. Extramural Research, National Institute on and will be determined by the number The meetings will be closed to the Drug Abuse, NIH, DHHS, 6001 Executive of speakers who register on-site. public in accordance with the Boulevard, Room 4234, MSC 9550, Bethesda, VerDate Sep<11>2014 19:21 Jun 22, 2017 Jkt 241001 PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 E:\FR\FM\23JNN1.SGM 23JNN1

28674 Federal Register / Vol. 82, No. 120 / Friday, June 23, 2017 / Notices MD 20892, 301–827–5840, Contact Person: Zhuqing (Charlie) Li, FOR FURTHER INFORMATION CONTACT: julia.berzhanskaya@nih.gov. Ph.D., Scientific Review Officer, Scientific Virginia Sardone, Director, Office of Name of Committee: National Institute on Review Program, Division of Extramural Affordable Housing Programs, Room Drug Abuse Special Emphasis Panel; Activities, Room #3G41B, National Institutes of Health/NIAID, 5601 Fishers Lane, 7164, Department of Housing and Urban Expanding Medication Assisted Treatment for Opioid Use Disorders in the Context of MSC9823, Bethesda, MD 20892–9823, (240) Development, 451 Seventh Street SW., the SAMHSA Opioid STR Grants (R21/R33). 669–5068, zhuqing.li@nih.gov. Washington, DC 20410–7000; telephone Date: July 25, 2017. Name of Committee: National Institute of (202) 708–2684. (This is not a toll-free Time: 12:00 p.m. to 3:00 p.m. Allergy and Infectious Diseases Special number.) A telecommunications device Agenda: To review and evaluate grant Emphasis Panel; LIMITED COMPETITION: for hearing- and speech-impaired applications. CTOT–C MECHANISTIC ANCILLARY persons (TTY) is available at 800–877– Place: National Institutes of Health, STUDIES (U01). 8339 (Federal Relay Service). Neuroscience Center, 6001 Executive Date: July 18, 2017. Boulevard, Rockville, MD 20852 (Telephone Time: 9:30 a.m. to 5:00 p.m. SUPPLEMENTARY INFORMATION: Section Conference Call). Agenda: To review and evaluate grant 1131 of HERA Division A amended the Contact Person: Hiromi Ono, Ph.D., applications. Act to add a new section 1337 entitled Scientific Review Officer, Office of Place: National Institutes of Health, 5601 Extramural Policy and Review, National Fishers Lane, Rockville, MD 20892 ‘‘Affordable Housing Allocations’’ and a Institute on Drug Abuse, National Institutes (Telephone Conference Call). new section 1338 entitled ‘‘Housing of Health, DHHS, 6001 Executive Boulevard, Contact Person: Zhuqing (Charlie) Li, Trust Fund.’’ HUD’s implementing Room 4238, MSC 9550, Bethesda, MD 20892, Ph.D., Scientific Review Officer, Scientific regulations are codified at 24 CFR part 301–827–5820, hiromi.ono@nih.gov. Review Program, Division of Extramural 93. Congress authorized the HTF with (Catalogue of Federal Domestic Assistance Activities, Room #3G41B, National Institutes the stated purpose of: (1) Increasing and Program Nos.: 93.279, Drug Abuse and of Health/NIAID, 5601 Fishers Lane, MSC9823, Bethesda, MD 20892–9823, (240) preserving the supply of rental housing Addiction Research Programs, National 669–5068, zhuqing.li@nih.gov. for extremely low-income families with Institutes of Health, HHS) (Catalogue of Federal Domestic Assistance incomes between 0 and 30 percent of Dated: June 19, 2017. area median income and very low- Program Nos. 93.855, Allergy, Immunology, Natasha M. Copeland, and Transplantation Research; 93.856, income families with incomes between Program Analyst, Office of Federal Advisory Microbiology and Infectious Diseases 30 and 50 percent of area median Committee Policy. Research, National Institutes of Health, HHS) income, including homeless families, [FR Doc. 2017–13078 Filed 6–22–17; 8:45 am] Dated: June 19, 2017. and (2) increasing homeownership for BILLING CODE 4140–01–P Natasha M. Copeland, extremely low-income and very low- Program Analyst, Office of Federal Advisory income families. Section 1337 of the Act Committee Policy. provides for the HTF (and other DEPARTMENT OF HEALTH AND [FR Doc. 2017–13077 Filed 6–22–17; 8:45 am] programs) to be funded with an HUMAN SERVICES BILLING CODE 4140–01–P affordable housing set-aside by Fannie National Institutes of Health Mae and Freddie Mac. The total set- aside amount is equal to 4.2 basis points National Institute of Allergy and DEPARTMENT OF HOUSING AND (.042 percent) of Fannie Mae and Infectious Diseases; Notice of Closed URBAN DEVELOPMENT Freddie Mac’s new mortgage purchases, Meetings a portion of which is for the HTF. [Docket No. FR–6036–N–01] Section 1338 of the Act directs HUD to Pursuant to section 10(d) of the establish, through regulation, the Federal Advisory Committee Act, as Housing Trust Fund Federal Register; formula for distribution of amounts amended (5 U.S.C. App.), notice is Allocation Notice made available for the HTF. The statute hereby given of the following meetings. AGENCY: Office of the Assistant specifies the factors to be used for the The meetings will be closed to the Secretary for Community Planning and formula and priority for certain factors. public in accordance with the Development, HUD. The factors and methodology HUD uses provisions set forth in sections to allocate HTF funds among eligible ACTION: Notice of Fiscal Year 2017 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., grantees are established in the HTF as amended. The grant applications and Funding Awards. regulation. The funding announced for the discussions could disclose SUMMARY: The Housing and Economic Fiscal Year 2017 through this notice is confidential trade secrets or commercial Recovery Act of 2008 (HERA) $219,168,373.94. This amount includes property such as patentable material, established the Housing Trust Fund and personal information concerning $12,702,747 of unobligated Fiscal Year (HTF) to be administered by HUD. 2016 HTF funds that will be reallocated individuals associated with the grant Pursuant to the Federal Housing applications, the disclosure of which by formula, which are comprised of Enterprises Financial Security and $37,298 from American Samoa, Guam, would constitute a clearly unwarranted Soundness Act of 1992 (the Act), as invasion of personal privacy. and the Commonwealth of Northern amended by HERA, Division A, eligible Mariana Islands, three Insular Areas that Name of Committee: National Institute of HTF grantees are the 50 states, the declined their Fiscal Year 2016 asabaliauskas on DSKBBXCHB2PROD with NOTICES Allergy and Infectious Diseases Special District of Columbia, the Emphasis Panel; NIAID CLINICAL TRIAL allocations and $12,665,449 of Commonwealth of Puerto Rico, PLANNING GRANT (R34). American Samoa, Guam, the Sequestered Fiscal Year 2016 funds. Date: July 17, 2017. Commonwealth of Northern Mariana HUD may add any amounts that may Time: 2:00 p.m. to 5:00 p.m. become available to these FY 2017 HTF Agenda: To review and evaluate grant Islands, and the United States Virgin Islands. In accordance with Section allocation amounts. Appendix A to this applications. 1338(c)(4)(A) of the Act, this notice notice provides the names of the Place: National Institutes of Health, 5601 Fishers Lane, Rockville, MD 20892 announces the formula allocation grantees and the amounts of the awards. (Telephone Conference Call). amount for each eligible HTF grantee. VerDate Sep<11>2014 19:21 Jun 22, 2017 Jkt 241001 PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 E:\FR\FM\23JNN1.SGM 23JNN1


Document Created: 2017-06-23 03:37:27
Document Modified: 2017-06-23 03:37:27
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesJune 30, 2017.
FR Citation82 FR 28673 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR